The risk or severity of adverse effects can be increased when Valsartan is combined with Diltiazem. The metabolism of Vismodegib can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Meclofenamic acid. The serum concentration of Bosentan can be increased when it is combined with Valsartan. Valsartan may increase the hypotensive activities of Tolazoline. The metabolism of Mestranol can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Olsalazine. The risk or severity of adverse effects can be increased when Valsartan is combined with Benzydamine. The risk or severity of adverse effects can be increased when Isoflurane is combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Imidapril. The risk or severity of adverse effects can be increased when Valsartan is combined with Torasemide. The risk or severity of adverse effects can be increased when Valsartan is combined with Betaxolol. Valsartan may increase the hypotensive activities of Hydroflumethiazide. The metabolism of Rofecoxib can be decreased when combined with Valsartan. The metabolism of Sulfamoxole can be decreased when combined with Valsartan. The metabolism of Trimipramine can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Terazosin. The risk or severity of adverse effects can be increased when Valsartan is combined with Pirfenidone. The risk or severity of adverse effects can be increased when Valsartan is combined with Bendroflumethiazide. The metabolism of Tenoxicam can be decreased when combined with Valsartan. Canagliflozin may increase the hyperkalemic activities of Valsartan. The metabolism of Alosetron can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Levosimendan is combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Nimesulide. The risk or severity of adverse effects can be increased when Valsartan is combined with Epirizole. The risk or severity of adverse effects can be increased when Valsartan is combined with Apocynin. The metabolism of Glimepiride can be decreased when combined with Valsartan. The metabolism of Valsartan can be decreased when combined with Fluconazole. The metabolism of Valsartan can be decreased when combined with Nicardipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Nitroprusside. The serum concentration of Valsartan can be increased when it is combined with Mifepristone. The risk or severity of adverse effects can be increased when Valsartan is combined with Captopril. Valsartan may increase the hypotensive activities of Manidipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Telmisartan. The metabolism of Bexarotene can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Irbesartan. The risk or severity of adverse effects can be increased when Carbetocin is combined with Valsartan. Tadalafil may increase the antihypertensive activities of Valsartan. Valsartan may increase the hypotensive activities of Travoprost. The risk or severity of adverse effects can be increased when Valsartan is combined with Pimecrolimus. The metabolism of Chlorpropamide can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Morphine is combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Dapagliflozin. Alfuzosin may increase the hypotensive activities of Valsartan. The metabolism of Cisapride can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Amiloride. The risk or severity of adverse effects can be increased when Valsartan is combined with Ketorolac. The risk or severity of adverse effects can be increased when Valsartan is combined with Triamterene. The metabolism of Acenocoumarol can be decreased when combined with Valsartan. The metabolism of Ibuprofen can be decreased when combined with Valsartan. The metabolism of Netupitant can be decreased when combined with Valsartan. The metabolism of Valsartan can be decreased when combined with Floxuridine. The metabolism of Caffeine can be decreased when combined with Valsartan. The metabolism of Mirtazapine can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Sevoflurane is combined with Valsartan. Valsartan may increase the hypotensive activities of Remikiren. The risk or severity of adverse effects can be increased when Valsartan is combined with Cilazapril. The risk or severity of adverse effects can be increased when Valsartan is combined with Benazepril. The metabolism of Amprenavir can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Clonidine. The risk or severity of adverse effects can be increased when Valsartan is combined with Droxicam. The metabolism of Pravastatin can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Olopatadine. The metabolism of Idarubicin can be decreased when combined with Valsartan. The metabolism of Valsartan can be decreased when combined with Fluvastatin. Valsartan may increase the hypotensive activities of Terlipressin. The risk or severity of adverse effects can be increased when Valsartan is combined with Carteolol. Valsartan may increase the hypotensive activities of Pentolinium. The risk or severity of adverse effects can be increased when Valsartan is combined with Bucillamine. The metabolism of Valsartan can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Valsartan is combined with Penbutolol. The metabolism of Tapentadol can be decreased when combined with Valsartan. The metabolism of Apixaban can be decreased when combined with Valsartan. Vardenafil may increase the antihypertensive activities of Valsartan. Nadroparin may increase the hyperkalemic activities of Valsartan. Tolvaptan may increase the hyperkalemic activities of Valsartan. The metabolism of Valsartan can be decreased when combined with Lobeglitazone. Parnaparin may increase the hyperkalemic activities of Valsartan. The metabolism of Salicylic acid can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Enalapril. Valsartan may increase the hypotensive activities of Latanoprost. The metabolism of Doxepin can be decreased when combined with Valsartan. Trimethaphan may increase the hypotensive activities of Valsartan. The metabolism of Etravirine can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Mannitol. The metabolism of Valsartan can be decreased when combined with Zafirlukast. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Valsartan. The metabolism of Estrone can be decreased when combined with Valsartan. The metabolism of Treprostinil can be decreased when combined with Valsartan. The metabolism of Candesartan can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Chlorthalidone. The metabolism of Quazepam can be decreased when combined with Valsartan. The metabolism of Bupropion can be decreased when combined with Valsartan. Octamoxin may increase the hypotensive activities of Valsartan. The metabolism of Warfarin can be decreased when combined with Valsartan. Valsartan may increase the hypotensive activities of Guanethidine. The risk or severity of adverse effects can be increased when Valsartan is combined with Doxazosin. Hydrochlorothiazide may increase the hypotensive activities of Valsartan. Valsartan may increase the hypotensive activities of Selexipag. Valsartan may increase the hypotensive activities of Efonidipine. Aripiprazole may increase the hypotensive activities of Valsartan. The metabolism of Valsartan can be decreased when combined with Ticagrelor. Valsartan may increase the hypotensive activities of Celiprolol. Isocarboxazid may increase the hypotensive activities of Valsartan. The risk or severity of adverse effects can be increased when Amphotericin B is combined with Valsartan. The metabolism of Olodaterol can be decreased when combined with Valsartan. Valsartan may increase the hyperkalemic activities of Drospirenone. Dalteparin may increase the hyperkalemic activities of Valsartan. The metabolism of Terbinafine can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Omapatrilat. The risk or severity of adverse effects can be increased when Ropivacaine is combined with Valsartan. The risk or severity of adverse effects can be increased when Streptokinase is combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Bretylium. Moxonidine may increase the hypotensive activities of Valsartan. The metabolism of Thiamylal can be decreased when combined with Valsartan. The metabolism of Nateglinide can be decreased when combined with Valsartan. The metabolism of Ximelagatran can be decreased when combined with Valsartan. The metabolism of Promazine can be decreased when combined with Valsartan. The metabolism of Loratadine can be decreased when combined with Valsartan. Valsartan may increase the hypotensive activities of Naftopidil. The metabolism of Moclobemide can be decreased when combined with Valsartan. The metabolism of Azelastine can be decreased when combined with Valsartan. The metabolism of Gavestinel can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Verapamil. The metabolism of Enasidenib can be decreased when combined with Valsartan. Valsartan may increase the hypotensive activities of Saprisartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Isoxicam. The metabolism of Valsartan can be decreased when combined with Abiraterone. The risk or severity of adverse effects can be increased when Valsartan is combined with PTC299. The risk or severity of adverse effects can be increased when Valsartan is combined with Balsalazide.